Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Endocrine 2Thoracic 1Sarcoma 1NET 1Gynecologic 1CNS 1

Conditions

Colorectal Neoplasms 450Stomach Neoplasms 295Rectal Neoplasms 271Colonic Neoplasms 192Pancreatic Neoplasms 177Neoplasm Metastasis 94Esophageal Neoplasms 88Carcinoma, Hepatocellular 60Adenocarcinoma Of Esophagus 47Cholangiocarcinoma 46Neoplasms 42Biliary Tract Neoplasms 38Gallbladder Neoplasms 31Adenocarcinoma 30Gastrointestinal Neoplasms 29Liver Neoplasms 25Esophageal Squamous Cell Carcinoma 23Carcinoma, Non-Small-Cell Lung 18Bile Duct Neoplasms 17Parkinson Disease 4, Autosomal Dominant Lewy Body 13Locally Advanced Rectal Cancer 13Colorectal Cancer Metastatic 11Appendiceal Neoplasms 11Recurrence 10Peritoneal Neoplasms 10Ovarian Neoplasms 9Carcinoma 7Breast Neoplasms 7Neurotoxicity Syndromes 6Gastrointestinal Diseases 6

Interventions

Trastuzumab 2Oxaliplatin 2Melphalan 2Leucovorin 2tipifarnib 1napabucasin 1irinotecan sucrosofate 1folfirinox 1Temozolomide 1Taxes 1Sunitinib 1Paclitaxel 1Irinotecan 1Interleukin-12 Subunit p35 1Interleukin-12 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Fluorouracil 1Floxuridine 1Filgrastim 1Fentanyl 1Everolimus 1Cytokines 1Capecitabine 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Islet Cell × Oxaliplatin × Gastrointestinal × Clear all
NCT02231723 2023-11-18

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

Sumitomo Pharma America, Inc.

Phase 1 Completed
139 enrolled
Gastrointestinal

Pancreatic cancer, adult, Digestive System Neoplasms, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Islet Cell, Carcinoma, Pancreatic Ductal

NCT00005860 2011-04-26

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

National Cancer Institute (NCI)

Phase 1 Completed
CNSEndocrineGastrointestinalGynecologicSarcoma

Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Vipoma, Fallopian Tube Neoplasms, Gallbladder Neoplasms, Glucagonoma, Carcinoma, Hepatocellular, Insulinoma, Neoplasms, Neoplasms, Unknown Primary, Neuroblastoma, Pancreatic Neoplasms, Pheochromocytoma, Pseudomyxoma Peritonei, Somatostatinoma, Stomach Neoplasms, Gastrinoma, Carcinoma, Islet Cell, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡